Sunny Optical Technology Total Assets 2019-2019 | SNPTF

Sunny Optical Technology total assets from 2019 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Sunny Optical Technology total assets for the quarter ending June 30, 2019 were $3.453B, a INF% increase year-over-year.
  • Sunny Optical Technology total assets for 2018 were $3.453B, a INF% increase from 2016.
  • Sunny Optical Technology total assets for 2016 were $0B, a NAN% decline from 2015.
  • Sunny Optical Technology total assets for 2015 were $0B, a NAN% decline from .
Sunny Optical Technology Annual Total Assets
(Millions of US $)
2018 $3,453
2016 $0
2015 $0
Sunny Optical Technology Quarterly Total Assets
(Millions of US $)
2018-12-31 $3,453
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.566B $3.918B
Sunny Optical Technology Group Co., Limited is engaged in the design, research and development, manufacture and sales of optical and optical-related products. Optical components product includes glass spherical and aspherical lenses, plane products, handset lens sets, vehicle lens sets and other various lens sets. Optoelectronic products includes handset camera modules, three-dimensional optoelectronic products, security cameras and other optoelectronic modules and optical instruments includes microscopes, optical measuring instruments and various high-end optical analytical instrument. Sunny Optical Technology Group Co., Limited is based in Yuyao, the People's Republic of China.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $176.761B 33.20
Medtronic (MDT) Ireland $129.154B 20.98
Stryker (SYK) United States $70.955B 27.51
Boston Scientific (BSX) United States $51.986B 30.70
Lonza Group Ag (LZAGY) Switzerland $46.178B 0.00
Baxter (BAX) United States $41.045B 25.10
Terumo (TRUMY) Japan $29.530B 37.75
ResMed (RMD) United States $29.334B 46.29
EssilorLuxottica Societe Anonyme (ESLOY) France $28.492B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.965B 22.45
Smith & Nephew SNATS (SNN) United Kingdom $17.585B 0.00
Bio-Rad Laboratories (BIO) United States $15.620B 70.72
Insulet (PODD) United States $13.019B 1289.81
Quidel (QDEL) United States $12.525B 66.35
Shandong Weigao Medical Polymer (SHWGF) China $11.849B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
Perrigo (PRGO) Ireland $7.514B 13.44
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.165B 0.00
Hill-Rom Holdings (HRC) United States $6.311B 15.66
GW Pharmaceuticals (GWPH) United Kingdom $4.203B 0.00
Neogen (NEOG) United States $4.135B 69.10
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.995B 0.00
Haemonetics (HAE) United States $3.842B 25.80
ICU Medical (ICUI) United States $3.834B 27.97
Envista Holdings (NVST) United States $3.641B 24.83
Abcam (ABCZY) $3.406B 0.00
Agios Pharmaceuticals (AGIO) United States $3.048B 0.00
NuVasive (NUVA) United States $2.754B 38.38
National Vision Holdings (EYE) United States $2.703B 46.76
TG Therapeutics (TGTX) United States $2.246B 0.00
AtriCure (ATRC) United States $1.854B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.706B 157.08
MacroGenics (MGNX) United States $1.438B 0.00
Aphria (APHA) Canada $1.408B 0.00
NanoString Technologies (NSTG) United States $1.349B 0.00
Aurora Cannabis (ACB) Canada $1.239B 0.00
Cerus (CERS) United States $1.225B 0.00
OraSure Technologies (OSUR) United States $1.197B 241.13
Vapotherm (VAPO) United States $1.124B 0.00
Meridian Bioscience (VIVO) United States $1.091B 41.06
Cardiovascular Systems (CSII) United States $1.086B 0.00
PetIQ (PETQ) United States $1.062B 30.68
InMode (INMD) Israel $1.053B 22.24
Owens & Minor (OMI) United States $1.047B 23.74
Phibro Animal Health (PAHC) United States $0.951B 18.96
Quanterix (QTRX) United States $0.934B 0.00
Omeros (OMER) United States $0.714B 0.00
BioLife Solutions (BLFS) United States $0.670B 190.82
Eagle Pharmaceuticals (EGRX) United States $0.659B 47.18
Surmodics (SRDX) United States $0.640B 77.15
VAREX IMAGING (VREX) United States $0.636B 15.80
Zynex (ZYXI) United States $0.626B 54.70
LeMaitre Vascular (LMAT) United States $0.595B 36.42
Lantheus Holdings (LNTH) United States $0.503B 11.72
Viemed Healthcare (VMD) United States $0.434B 38.48
Cytosorbents (CTSO) United States $0.341B 0.00
HEXO (HEXO) $0.338B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.331B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.33
InfuSystems Holdings (INFU) United States $0.256B 141.56
Organigram Holdings (OGI) Canada $0.228B 0.00
Female Health (VERU) United States $0.214B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Exagen (XGN) United States $0.177B 0.00
Bovie Medical (APYX) United States $0.168B 0.00
Fonar (FONR) United States $0.161B 14.24
Surface Oncology (SURF) United States $0.159B 0.00
Wound Management Technologies (SMTI) United States $0.149B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.126B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Capricor Therapeutics (CAPR) United States $0.115B 0.00
Evolus (EOLS) United States $0.106B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
Nephros (NEPH) United States $0.076B 0.00
United-Guardian (UG) United States $0.072B 16.78
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.034B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00